Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2006
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study GroupC Nickenig, M Dreyling, E Hoster, et al.
Leukemia|July 19, 2014
The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphomaS Robinson, P Dreger, D Caballero, et al.
Leukemia|March 14, 2015
Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphomaG Hess, U Keller, C W Scholz, et al.
Oncogene|November 6, 2007
Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphomaH Stöcklein, J Smardova, J Macak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2012
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)M Ghielmini, U Vitolo, E Kimby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2016
Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHLK Koch, E Hoster, M Ziepert, et al.
Annals of Hematology|August 29, 2012
Current treatment of mantle cell lymphoma: results of a national survey and consensus meetingM Witzens-Harig, G Hess, J Atta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2013
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphomaM Dreyling, C Thieblemont, A Gallamini, et al.
Bone Marrow Transplantation|February 3, 2015
Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphomaA-K Zoellner, S Fritsch, D Prevalsek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2007
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphomaF Morschhauser, J F Seymour, H C Kluin-Nelemans, et al.
Pageof 5